Background: Immediate hypersensitivity reactions are a hallmark of allergic disease, and result in the clinical features of food allergy, hayfever, and atopic asthma. The mechanism by which an individual becomes sensitized to an ingested or airborne allergen is not clear, however exposure to bacteria or bacterial products that act as adjuvants may be a contributing factor. The purpose of this study was to examine the role of pertussis toxin (PT) in inducing intestinal hypersensitivity reactions, particularly the ability of the adjuvant to prolong the sensitization. Methods: Rats were sensitized to ovalbumin (OA) by injection of OA alone or with 50 ng PT. Secretory responses to OA challenge and nerve stimulation were assessed in jejunal tissues mounted in Ussing chambers. Results: Jejunal segments from rats sensitized to OA alone responded to antigen challenge with ion secretion, but sensitization was transient in that specific IgE titers and responses to luminal antigen disappeared by 14 days. In contrast, co–administration of 50 ng PT with OA resulted in long–lasting sensitization. Secretory responses to both luminal and serosal OA challenge were present 8 months after primary immunization. Enhanced secretory responses to nerve stimulation, increased mucosal mast cell numbers, as well as elevated IgE titers were also induced and may have contributed to the overall responsiveness of the intestine to antigen challenge. Conclusions: Our findings indicate nanogram quantities of PT, when administered with a food protein, result in long–term sensitization to the antigen, and altered intestinal neuroimmune function. These data suggest that exposure to bacterial pathogens may prolong the normally transient immune responsiveness to inert food antigens.

Keywords:
Intestine, Epithelium, Nerve, Ion transport, Mast cell, Hypersensitivity, Immunoglobulin E
1.
Serafin WE, Austen KE: Mediators of immediate hypersensitivity reactions. N Engl J Med 1987;317:30–34.
2.
Cuthbert AW, McLaughlan P, Coombs RRA: Immediate hypersensitivity reaction to β–lactoglobulin in the epithelium lining the colon of guinea pigs fed cow’s milk. Int Arch Allergy Appl Immunol 1983;72:34–40.
3.
Perdue MH, Chung M, Gall DG: The effect of intestinal anaphylaxis on gut function in the rat. Gastroenterology 1984;86;391–397.
4.
Crowe SE, Sestini P, Perdue MH: Allergic reactions of rat jejunal mucosa: Ion transport responses to luminal antigen and inflammatory mediators. Gastroenterology 1990;99:74–82.
5.
Javed NH, Wang Y, Cooke HJ: Neuroimmune interactions: Role for cholinergic neurons in intestinal anaphylaxis. Am J Physiol 1992; 263:G847–G852.
6.
Castro GA, Harari Y, Russell D: Mediators of anaphylaxis–induced ion transport changes in small intestine. Am J Physiol 1987;253:G540– G548.
7.
Holt PG, Vines J, Bilyk N: Effect of influenza virus infection on allergic sensitization to inhaled antigen in mice. Int Arch Allergy Appl Immunol 1988;86:121–123.
8.
Levy DA, Dorat A, Pinel AM, Normier G, Dussourd L, Hinterland D, David B: Relationship between bacteria and IgE. Int Arch Allergy Appl Immunol 1989;88:237–239.
9.
Kosecka U, Marshall JS, Crowe SE, Bienenstock J, Perdue MH: Pertussis toxin stimulates hypersensitivity and enhances nerve–mediated antigen uptake in rat intestine. Am J Physiol 1994;267:G745–G753.
10.
Snider DP, Marshall JS, Perdue MH, Liang H: Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J Immunol 1994;153:647–657.
11.
Kaslow HR, Burns DL: Pertussis toxin and target eukaryotic cells: Binding, entry, and activation. FASEB J 1992;6:2684–2690.
12.
Tada T, Okumura, K, Platteau B, Beckers A, Bazin H: Half–lives of two types of rat homocytotropic antibodies in circulation and in the skin. Int Arch Allergy Appl Immunol 1975;48: 116–131.
13.
Berin MC, Kiliaan AJ, Yang PC, Groot JA, Taminiau JA, Perdue MH: Rapid transepithelial antigen transport in rat jejunum: Impact of sensitization and the hypersensitivity reaction. Gastroenterology 1997;113:856–864.
14.
Mu H, Sewell WA: Enhancement of interleukin–4 production by pertussis toxin. Infect Immun 1993;61:2834–2840.
15.
Finkelman FD, Holmes J, Katona IM, Urban JF, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosman TR, Paul WE: Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990;8: 303–333.
16.
Kopf M, Gros GL, Bachmann M, Lamers MC, Bluethmann H, Koehler G: Disruption of the murine IL–4 gene blocks Th2 cytokine responses. Nature 1993;362:245–248.
17.
Berlin MC, Ciok LA, Yang PC, Pedue MH: Altered epithelial barrier function in a sensitized host in present in the absence of inflammation (abstract). Gastroenterology 1998;114:A930.
18.
Kimm MH, Curtis GH, Hardin JA, Gall DG: Transport of bovine serum albumin across rat jejunum: Role of the enteric nervous system. Am J Physiol 1994;266:G186–G193.
19.
Bijlsma PB, Kiliaan AJ, Scholten G, Heyman M, Groot JA: Carbachol, but not forskolin, increases mucosal–to–serosal transport of intact protein in rat ileum in vitro. Am J Physiol 1996;271:G147–G152.
20.
Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet J, Galli SJ: IgE enhances mouse mast cell FcεRI expression in vitro and in vivo: Evidence for a novel amplification mechanism in IgE–dependent reactions. J Exp Med 1997;185:663–672.
21.
Perdue MH, Masson S, Wershil BK, Galli SJ: Role of mast cells in ion transport abnormalities associated with intestinal anaphylaxis: Correction of the diminished secretory response in genetically mast cell–deficient w/wv mice by bone marrow transplantation. J Clin Invest 1991;87:687–693.
22.
Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J: Intestinal mucosal mast cells in normal and nematode–infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 1987;84:2975–2979.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.